Arkolith/Insider Trading/BIOR/Form 4

Athyrium Funds GP Holdings LLC

Director, 10% OwnerBIORA THERAPEUTICS, INC. (BIOR) · full profile →Form 4 · filed Sep 19, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2023Grant(A)9.2M——10.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 18, 2023Disposed to issuer(D)50.0M——53.5M
Sep 18, 2023Grant(A)16.6M——16.6M
Sep 18, 2023Grant(A)7.4M——7.4M

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-019263) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML